| Product NDC: | 48818-001 |
| Proprietary Name: | Folotyn |
| Non Proprietary Name: | pralatrexate |
| Active Ingredient(s): | 20 mg/mL & nbsp; pralatrexate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 48818-001 |
| Labeler Name: | Allos Therapeutics |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022468 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090924 |
| Package NDC: | 48818-001-02 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (48818-001-02) > 2 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 48818-001-02 |
| Proprietary Name | Folotyn |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (48818-001-02) > 2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 48818-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pralatrexate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090924 |
| Marketing Category Name | NDA |
| Labeler Name | Allos Therapeutics |
| Substance Name | PRALATREXATE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC] |